CSL Behring Lengnau AG

Registered sites: 0
Drug products: 12
Live patents: 0
Countries: 0
Base: Unknown

Sites

Facilities

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Catalogue

Marketed products

Showing 12 of 12.

Brand	Generic name	Form	Category
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain	ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT	KIT	BLA
IDELVION	Coagulation Factor IX Recombinant Human	KIT	BLA
IDELVION	Coagulation Factor IX Recombinant Human	KIT	BLA
IDELVION	Coagulation Factor IX Recombinant Human	KIT	BLA
IDELVION	Coagulation Factor IX Recombinant Human	KIT	BLA
IDELVION	Coagulation Factor IX Recombinant Human	KIT	BLA

Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.